Boston Scientific’s Synergy Megatron [Image from Boston Scientific]
Boston Scientific: Synergy Megatron
Boston Scientific is expected to launch its Synergy Megatron bioabsorbable polymer coronary stent system in fiscal year 2020.
Synergy Megatron is designed for large proximal vessels, including left main, bifurcations and ostial lesions. It is available in 3.5 mm to 5.0 mm diameters. It boasts increased strength and the ability to accommodate tapered vessels
It has fully launched in Europe and is expected to receive FDA approval in 2020.
